frenova.com

What It Is

Frenova is a global clinical research site management organization focused on kidney disease–related clinical trials, including ESKD, CKD, and adjacent disease research. It is not a typical self-service SaaS platform, but rather a specialized clinical research service provider that combines a research site network, patient resources, project management, and data analytics licensing.

Core Capabilities

The official website emphasizes its relationship with Fresenius Medical Care, which gives it access to a large global population of ESKD and CKD patients. Through its F1RST UP site network, Frenova helps research programs launch quickly, covering feasibility assessment, IRB submissions, budgets, contracts, patient screening, and recruitment. It also has longitudinal kidney disease data from more than 2 million patients spanning over 25 years, which can be used for data analytics and licensing services. In project execution, clinical project managers serve as a single point of contact, supporting communication and operational efficiency throughout the full trial lifecycle.

Pricing and Business Model

The website does not disclose standard packages, subscription pricing, usage-based billing, or free trial information, and only provides a “Request a Proposal” entry point. Therefore, its business model is more likely based on project-based, customized services or data licensing partnerships. Specific pricing needs to be confirmed with the sales or project team.

Pros and Cons

Its strength lies in its highly concentrated vertical resources: a kidney disease patient network, long-term longitudinal data, and site startup experience create a significant barrier to entry. For clinical trials that need to recruit kidney disease patients quickly, its value is relatively clear. The limitation is that publicly available information provides insufficient detail about its productized software capabilities, such as third-party integrations, APIs, deployment methods, permission systems, and security and compliance certifications, none of which are disclosed. If a buyer evaluates it according to enterprise software standards, further due diligence will be needed.

Who It’s For

Frenova is suitable for pharmaceutical companies, biotech companies, CROs, and research institutions, especially teams conducting clinical research on CKD, ESKD, kidney disease, and related conditions. It is less suitable to purchase as a general-purpose clinical trial management SaaS, data platform, or internal collaboration tool.

Access in China

Based on the crawled text, it is not possible to determine the stability of access from mainland China, or whether it has local nodes or ICP filing information. For now, this is rated as unknown.